Cargando…
The Absence of PTEN in Breast Cancer Is a Driver of MLN4924 Resistance
Background: Numerous studies have indicated that the neddylation pathway is closely associated with tumor development. MLN4924 (Pevonedistat), an inhibitor of the NEDD8-activating E1 enzyme, is considered a promising chemotherapeutic agent. Recently, we demonstrated that neddylation of the tumor sup...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120322/ https://www.ncbi.nlm.nih.gov/pubmed/33996822 http://dx.doi.org/10.3389/fcell.2021.667435 |